330 related articles for article (PubMed ID: 11464864)
1. The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.
Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern CP; Kogner P
Med Pediatr Oncol; 2001 Jan; 36(1):127-31. PubMed ID: 11464864
[TBL] [Abstract][Full Text] [Related]
2. The synthetic retinoid RO 13-6307 induces neuroblastoma differentiation in vitro and inhibits neuroblastoma tumour growth in vivo.
Ponthan F; Johnsen JI; Klevenvall L; Castro J; Kogner P
Int J Cancer; 2003 Apr; 104(4):418-24. PubMed ID: 12584737
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat.
Ponthan F; Kogner P; Bjellerup P; Klevenvall L; Hassan M
Br J Cancer; 2001 Dec; 85(12):2004-9. PubMed ID: 11747346
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts.
Ponthan F; Lindskog M; Karnehed N; Castro J; Kogner P
Oncol Rep; 2003; 10(5):1587-92. PubMed ID: 12883745
[TBL] [Abstract][Full Text] [Related]
5. The somatostatin analogue octreotide inhibits neuroblastoma growth in vivo.
Borgström P; Hassan M; Wassberg E; Refai E; Jonsson C; Larsson SA; Jacobsson H; Kogner P
Pediatr Res; 1999 Sep; 46(3):328-32. PubMed ID: 10473050
[TBL] [Abstract][Full Text] [Related]
6. Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.
Reynolds CP
Curr Oncol Rep; 2000 Nov; 2(6):511-8. PubMed ID: 11122886
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis of N-type neuroblastoma cells after differentiation with 9-cis-retinoic acid and subsequent washout.
Lovat PE; Irving H; Annicchiarico-Petruzzelli M; Bernassola F; Malcolm AJ; Pearson AD; Melino G; Redfern CP
J Natl Cancer Inst; 1997 Mar; 89(6):446-52. PubMed ID: 9091647
[TBL] [Abstract][Full Text] [Related]
8. Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cells.
Veal GJ; Errington J; Redfern CP; Pearson AD; Boddy AV
Biochem Pharmacol; 2002 Jan; 63(2):207-15. PubMed ID: 11841795
[TBL] [Abstract][Full Text] [Related]
9. The effects of retinoic acid on the in vitro and in vivo growth of neuroblastoma cells.
Abemayor E
Laryngoscope; 1992 Oct; 102(10):1133-49. PubMed ID: 1328787
[TBL] [Abstract][Full Text] [Related]
10. Retinoids in neuroblastoma therapy: distinct biological properties of 9-cis- and all-trans-retinoic acid.
Lovat PE; Irving H; Annicchiarico-Petruzzelli M; Bernassola F; Malcolm AJ; Pearson AD; Melino G; Redfern CP
Eur J Cancer; 1997 Oct; 33(12):2075-80. PubMed ID: 9516856
[TBL] [Abstract][Full Text] [Related]
11. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
[TBL] [Abstract][Full Text] [Related]
12. Concentration-dependent effects of 9-cis retinoic acid on neuroblastoma differentiation and proliferation in vitro.
Lovat PE; Lowis SP; Pearson AD; Malcolm AJ; Redfern CP
Neurosci Lett; 1994 Nov; 182(1):29-32. PubMed ID: 7891881
[TBL] [Abstract][Full Text] [Related]
13. Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells.
Voigt A; Zintl F
Med Pediatr Oncol; 2003 Apr; 40(4):205-13. PubMed ID: 12555246
[TBL] [Abstract][Full Text] [Related]
14. Retinoids in pediatric onco-hematology: the model of acute promyelocytic leukemia and neuroblastoma.
Masetti R; Biagi C; Zama D; Vendemini F; Martoni A; Morello W; Gasperini P; Pession A
Adv Ther; 2012 Sep; 29(9):747-62. PubMed ID: 22941525
[TBL] [Abstract][Full Text] [Related]
15. Retinoid-induced differentiation of neuroblastoma: comparison between LG69, an RXR-selective analogue and 9-cis retinoic acid.
Irving H; Lovat PE; Hewson QC; Malcolm AJ; Pearson AD; Redfern CP
Eur J Cancer; 1998 Jan; 34(1):111-7. PubMed ID: 9624247
[TBL] [Abstract][Full Text] [Related]
16. The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid.
Coffey DC; Kutko MC; Glick RD; Butler LM; Heller G; Rifkind RA; Marks PA; Richon VM; La Quaglia MP
Cancer Res; 2001 May; 61(9):3591-4. PubMed ID: 11325825
[TBL] [Abstract][Full Text] [Related]
17. Synergistic anti-proliferative effects of vitamin D derivatives and 9-cis retinoic acid in SH-SY5Y human neuroblastoma cells.
Stio M; Celli A; Treves C
J Steroid Biochem Mol Biol; 2001 Jun; 77(4-5):213-22. PubMed ID: 11457659
[TBL] [Abstract][Full Text] [Related]
18. Anticancer Properties of Platinum Nanoparticles and Retinoic Acid: Combination Therapy for the Treatment of Human Neuroblastoma Cancer.
Gurunathan S; Jeyaraj M; Kang MH; Kim JH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947930
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro.
Ora I; Bondesson L; Jönsson C; Ljungberg J; Pörn-Ares I; Garwicz S; Pâhlman S
Biochem Biophys Res Commun; 2000 Oct; 277(1):179-85. PubMed ID: 11027660
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells.
Joshi S; Guleria R; Pan J; DiPette D; Singh US
Oncogene; 2006 Jan; 25(2):240-7. PubMed ID: 16158052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
